Inlexzo Underscores Growing Need for Urology, Oncology Pharmacy Integration

In an interview with Pharmacy Times, Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, director of pharmacy cancer care and an associate professor of pharmacy at Mayo Clinic College of Medicine and Science in Rochester, Minnesota, discussed how Inlexzo and increasingly complex urologic cancer therapies are driving closer coordination between urology and oncology pharmacy.